During the past decade, Baylor College of Medicine, Parkinson's Disease Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baylor College of Medicine, Parkinson's Disease Center" #1 sponsor was "Impax Laboratories, LLC" with 1 trials, followed by "Ipsen" with 1 trials sponsored, "Newron Pharmaceuticals SPA" with 1 trials sponsored, "Novartis" with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor College of Medicine, Parkinson's Disease Center" #1 collaborator was "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Baylor College of Medicine, Parkinson's Disease Center" are "Parkinson's Disease" (3 trials), "Cervical Dystonia" (1 trials) and "Parkinson's Disease With Cognitive Impairments" (1 trials). Many other conditions were trialed in "Baylor College of Medicine, Parkinson's Disease Center" in a lesser frequency.

Most popular intervention types in "Baylor College of Medicine, Parkinson's Disease Center" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Botulinum toxin type A" (1 trials), "Carbidopa/levodopa/entacapone" (1 trials), "IPX066 145 mg LD" (1 trials), "IPX066 195 mg LD" (1 trials) and "IPX066 245 mg LD" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baylor College of Medicine, Parkinson's Disease Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Baylor College of Medicine, Parkinson's Disease Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Baylor College of Medicine, Parkinson's Disease Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baylor College of Medicine, Parkinson's Disease Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".